Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P DiNitto

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and DifferentiationHonyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
Nature Communications|October 18, 2017
Regulation of T cell alloimmunity by PI3Kγ and PI3KδMayuko Uehara, Martina M McGrath, Shunsuke Ohori, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Chemistry & Biology|November 12, 2013
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease modelsDavid G Winkler, Kerrie L Faia, Jonathan P DiNitto, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and DifferentiationHonyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
Nature Communications|October 18, 2017
Regulation of T cell alloimmunity by PI3Kγ and PI3KδMayuko Uehara, Martina M McGrath, Shunsuke Ohori, et al.
Chemical Biology & Drug Design|October 22, 2009
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assayHaile Tecle, Frederic Feru, Hu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2009
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patientsKetan S Gajiwala, Joe C Wu, James Christensen, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Chemistry & Biology|November 12, 2013
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease modelsDavid G Winkler, Kerrie L Faia, Jonathan P DiNitto, et al.
Pageof 2